Scotland Eye Care Ltd SC527422 false 2023-03-01 2024-02-29 2024-02-29 The principal activity of the company is other letting and operating of own or leased real estate and provision of healthcare services. Digita Accounts Production Advanced 6.30.9574.0 true true SC527422 2023-03-01 2024-02-29 SC527422 2024-02-29 SC527422 bus:Director1 1 2024-02-29 SC527422 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2024-02-29 SC527422 core:RetainedEarningsAccumulatedLosses 2024-02-29 SC527422 core:ShareCapital 2024-02-29 SC527422 core:CurrentFinancialInstruments 2024-02-29 SC527422 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 SC527422 bus:SmallEntities 2023-03-01 2024-02-29 SC527422 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 SC527422 bus:FilletedAccounts 2023-03-01 2024-02-29 SC527422 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 SC527422 bus:RegisteredOffice 2023-03-01 2024-02-29 SC527422 bus:Director1 2023-03-01 2024-02-29 SC527422 bus:Director1 1 2023-03-01 2024-02-29 SC527422 bus:Director2 2023-03-01 2024-02-29 SC527422 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2023-03-01 2024-02-29 SC527422 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 SC527422 bus:Agent1 2023-03-01 2024-02-29 SC527422 core:LandBuildings 2023-03-01 2024-02-29 SC527422 countries:Scotland 2023-03-01 2024-02-29 SC527422 bus:Director1 1 2023-02-28 SC527422 2022-03-01 2023-02-28 SC527422 2023-02-28 SC527422 bus:Director1 1 2023-02-28 SC527422 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2023-02-28 SC527422 core:RetainedEarningsAccumulatedLosses 2023-02-28 SC527422 core:ShareCapital 2023-02-28 SC527422 core:CurrentFinancialInstruments 2023-02-28 SC527422 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 SC527422 bus:Director1 1 2022-03-01 2023-02-28 SC527422 bus:Director1 1 2022-02-28 iso4217:GBP xbrli:pure xbrli:shares

Registration number: SC527422

Scotland Eye Care Ltd

Unaudited Filleted Financial Statements

for the Year Ended 29 February 2024

 

Scotland Eye Care Ltd

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3

Notes to the Unaudited Financial Statements

4 to 6

 

Scotland Eye Care Ltd

Company Information

Directors

Dr Jonathan James Ross

Mrs Sarah Elizabeth Ross

Registered office

5 Ratho Park
Station Road
Newbridge
EH28 8QQ

Accountants

Deans Accountants And Business Advisors Ltd
27 North Bridge Street
Hawick
Scottish Borders
TD9 9BD

 

DEANS

Chartered Accountants

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Scotland Eye Care Ltd for the Year Ended 29 February 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Scotland Eye Care Ltd for the year ended 29 February 2024 as set out on pages 3 to 6 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants of Scotland (ICAS), we are subject to its ethical and other professional requirements which are detailed at http://www.icas.com/ethics/icas-code-of-ethics.

This report is made solely to the Board of Directors of Scotland Eye Care Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Scotland Eye Care Ltd and state those matters that we have agreed to state to the Board of Directors of Scotland Eye Care Ltd, as a body, in this report in accordance with ICAS guidance (www.icas.com/accountsprep/guidance). To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Scotland Eye Care Ltd and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Scotland Eye Care Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Scotland Eye Care Ltd. You consider that Scotland Eye Care Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Scotland Eye Care Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Deans Accountants And Business Advisors Ltd
27 North Bridge Street
Hawick
Scottish Borders
TD9 9BD

29 November 2024

 

Scotland Eye Care Ltd

(Registration number: SC527422)
Balance Sheet as at 29 February 2024

Note

2024
£

2023
£

Current assets

 

Debtors

4

707,013

1,034,272

Cash at bank and in hand

 

1,476

47,143

 

708,489

1,081,415

Creditors: Amounts falling due within one year

5

(209,924)

(203,274)

Net assets

 

498,565

878,141

Capital and reserves

 

Called up share capital

6

100

100

Retained earnings

498,465

878,041

Shareholders' funds

 

498,565

878,141

For the financial year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 29 November 2024 and signed on its behalf by:
 

.........................................
Dr Jonathan James Ross
Director

.........................................
Mrs Sarah Elizabeth Ross
Director

 

Scotland Eye Care Ltd

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

1

General information

The company is a private company limited by share capital, incorporated in Scotland.

The address of its registered office is:
5 Ratho Park
Station Road
Newbridge
EH28 8QQ

These financial statements were authorised for issue by the Board on 29 November 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The company is not directly impacted by Brexit.

The company has suffered financially from the pandemic. Where appropriate, government support in the forms of grants and loans were used to mitigate the impact of lockdowns etc. The directors will continue to assess the impact of the pandemic and make decisions accordingly.

The accounts are prepared in £ and are rounded to the nearest £1.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Scotland Eye Care Ltd

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Freehold property

Not depreciated

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2023 - 2).

4

Debtors

Current

2024
£

2023
£

Other debtors

707,013

1,034,272

 

707,013

1,034,272

 

Scotland Eye Care Ltd

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

5

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Taxation and social security

208,052

197,474

Accruals and deferred income

1,872

5,800

209,924

203,274

6

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

       

7

Related party transactions

Transactions with directors

2024

At 1 March 2023
£

Advances to director
£

Repayments by director
£

At 29 February 2024
£

Dr Jonathan James Ross

The company advanced loans to the director during the year. Interest is charged at 2.25%. There are no fixed terms for repayment.

1,020,434

688,384

(1,021,000)

687,818

2023

At 1 March 2022
£

Advances to director
£

Repayments by director
£

At 28 February 2023
£

Dr Jonathan James Ross

The company advanced loans to the director during the year. Interest is charged at 2.25%. There are no fixed terms for repayment.

617,271

1,023,163

(620,000)

1,020,434